{"schema_version":"secwatch.filing_event.v1","accession":"0001097149-26-000033","form_type":"8-K","ticker":"ALGN","cik":"0001097149","company_name":"ALIGN TECHNOLOGY INC","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.947844+00:00","generated_at":"2026-05-15T01:33:53.596588+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Align Technology reports Q1 revenue up 6.2% YoY, record Clear Aligner shipments, $200M buyback","bullets":["Q1 total revenues $1,040.1M, up 6.2% YoY; GAAP diluted EPS $1.57, non-GAAP EPS $2.58.","Record Clear Aligner shipments of 685.7k cases, up 6.7% YoY, driven by international double-digit growth.","Q2'26 revenue guidance $1,040M-$1,060M; full-year 2026 guidance reaffirmed (3-4% revenue growth).","Board approves $200M stock repurchase program to begin May 1, 2026; $800M remains under existing program.","Gross margin 70.8% GAAP (71.8% non-GAAP); operating margin 13.6% GAAP (21.5% non-GAAP)."],"urls":{"canonical":"https://secwatch.observer/filing/0001097149-26-000033","json":"https://secwatch.observer/filing/0001097149-26-000033.json","markdown":"https://secwatch.observer/filing/0001097149-26-000033.md","text":"https://secwatch.observer/filing/0001097149-26-000033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1097149/000109714926000033/0001097149-26-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1097149/000109714926000033/algn-20260429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T01:33:53.596588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"da98e1c5fa1ea951cde2954754258b18ce886cf7","claim":"ALIGN TECHNOLOGY INC reported first quarter ended March 31, 2026 results: revenue $1,040.1 million, net income $112.8 million, EPS $1.57 per diluted share. Guidance reaffirmed.","evidence_excerpt":"respectively Q1’26 Invisalign teen/kid patients increased 4.8% year-over-year and Invisalign adult patients increased 7.8% year-over-year • Q1'26 total revenues were $1,040.1 million, down 0.7% sequentially and up 6.2% year-over-year • Q1'26 total revenues were favorably impacted by foreign exchange by approximately $8.7 million sequentially, and favorably","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1097149/000109714926000033/0001097149-26-000033-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Revenue","value":"$1,040.1 million"},{"label":"Net income","value":"$112.8 million"},{"label":"EPS","value":"$1.57 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}